Dysfunction at the FDA, NIH, Elsewhere | Predictions for 2025
Predictions for this year from Perry Cohen, Pharm.D., CEO of the TPG Family of Companies and Managed Healthcare Executive editorial advisory board member.
The government’s role in impacting healthcare will be huge in 2025. The Trump administration’s primary objective is focused on undoing the work of previous administrations. They will disrupt healthcare delivery and financing by having people in leadership positions driven by politics and ideology who are not knowledgeable about and committed to the importance of evidence-based science and equitable social policy in advancing and regulating healthcare. HHS, the CDC, the FDA and the National Institutes of Health will lose considerable expertise and become dysfunctional.
Cohen
Access to healthcare will decrease due to undermining or eliminating the Affordable Care Act (ACA). Decreased funding for Medicaid will mean tighter requirements for enrollees. The tightening will be more severe in red states.
Quality of healthcare will decrease due to political and ideology-driven policy at both the federal and state levels due to the changes in Congress and at HHS and the impact of the Supreme Court’s Chevron decision. The out-of-pocket cost of healthcare will skyrocket for patients due to reductions in the ACA, Medicaid and cheap versions of health insurance with limited coverage. Medicare will prioritize Medicare Advantage plans over fee-for-service care, and for-profit healthcare companies will be the beneficiary.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Lifts Safety Restrictions on CAR T Therapies After Reviewing Real-World Data
July 2nd 2025FDA officials have determined that information regarding the risks for six CAR T-cell therapies can be communicated through product labeling, which includes a boxed warning for the risks of cytokine release syndrome and neurological toxicities.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
